Implications of Research Assessing Adverse Effects With Rosuvastatin Use

Jung-Im Shin, MD, PhD, assistant professor at Johns Hopkins University Bloomberg School of Public Health, discusses the results of her research regarding the risks of hematuria and proteinuria with rosuvastatin use.

Pharmacy Times interviewed Jung-Im Shin, MD, PhD, assistant professor at Johns Hopkins University Bloomberg School of Public Health, on her presentation at the American Society of Nephrology’s Kidney Week 2021 on the association of rosuvastatin use with the risk of hematuria and proteinuria.

During the interview, Shin discussed the results of her research regarding the risks of hematuria and proteinuria associated with rosuvastatin use, and what the implications of this research are in terms of statin treatment selection moving forward.